Print version of this report
TGA Action ID RC-2025-RN-00785-1
Type of Product Medical Device
Product Name/Description Heater Unit HU 35, 230V

Article Number: 701072162

Muliple Serial Numbers
ARTG Number 144010
Action Type Product Alert
Action Level Hospital
Hazard Classification Class II
Reason for the Action Getinge is issuing a Product Alert about a potential contamination with non-tuberculosis mycobacteria (NTM) for the Heater Unit HU 35.

The HU 35 acts as a heat supply in order to maintain the patient’s body temperature via a heat exchanger of a PLS oxygenator or HLS Module or other oxygenator-heat exchangers as part of extracorporeal circuits.

Due to an extended storage period with a specific range of serial numbers, there is an increased risk of bacterial growth. While disinfection at the end of production reduces microbial load, it may not eliminate all bacteria in the circuitry.

Four complaints regarding Mycobacteria chimaera contamination of the water circuitry that were part of the specific range of serial numbers have been reported. These contaminations were detected prior to any patient use. No patient infections caused by bacterial contamination have been reported to Maquet Cardiopulmonary for this device worldwide.
Instructions for Customers/Users Customers are to:

- Read the product alert and be aware of the potential for contamination with certain serial numbers.
- At the earliest opportunity, customers are to perform the descaling process of the water circuit with 2% citric acid according to chapter 8.2.1 of the IFU, and the high-level disinfection process with a concentration of 5% Chloramine T according to chapter 8.2.3.
- Customers are recommended to perform testing of the units affected for NTM after performing this high-level disinfection, prior to any further patient use.
- If there are still atypical mycobacteria in the water system detectable, repeat the high-level disinfection, and notify Getinge or lodge a TGA medical device incident report.
- Afterwards, follow the usual disinfection protocol as per IFU.
- Patients should be monitored as appropriate according to their facility’s standard of care.

The root cause investigation is ongoing, which will determine if further action is needed.
Action Commencement Date 15/09/2025
Responsible Entity Getinge Australia Pty Ltd
Contact Information 1800 438 464 - Getinge Customer Service